On August 3rd, Tekwon’s CTO signed a memorandum of R&D cooperation agreement with the representative of Avatex, Canada at Tekwon headquarters. The two companies will take advantage of their respective patent technologies to jointly accelerate the cooperative development of new peptide drugs and their listing in the Asia-Pacific market.